Composition for being internalized by enzyme and method

• 收藏
• 分享

专利权人:

REGENERON PHARMACEUTICALS; INC.

发明人:

ANDREW BAIK,KATHERINE CYGNAR

申请号：

BR112018011474

公开号：

BR112018011474A2

申请日:

2016.12.08

申请国别(地区):

BR

年份:

2018

代理人:

摘要：

The invention discloses the compositions and method for treating lysosomal storage disease.The invention discloses the biotherapeutic compounds that enzymatic activity is substituted containing internalization effect object binding structural domain and lysosome.Biotherapeutic compounds can enter cell, be isolated in lysosome, and be delivered to lysosome by enzymatic activity is substituted.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/